Emergent BioSolutions Inc (NYSE:EBS)
$ 10.745 -0.145 (-1.33%) Market Cap: 582.21 Mil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 1.47 GF Score: 63/100

Q4 2018 Emergent BioSolutions Inc Earnings Call Transcript

Feb 21, 2019 / 10:00PM GMT
Release Date Price: $63.72 (-2.19%)
Operator

Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 Emergent BioSolutions Inc. Earnings Conference Call. (Operator Instructions) I would now like to turn the conference over to Bob Burrows, VP of Investor Relations. You may begin.

Robert G. Burrows
Emergent BioSolutions Inc. - VP of IR

Thank you, Sonia, and good afternoon, everyone. Thank you for joining us today as we discuss the operational and financial results for the fourth quarter and 12 months of 2018.

As is customary, today's call is open to all participants, and in addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

Participating on the call with prepared comments will be Dan Abdun-Nabi, Chief Executive Officer; Bob Kramer, President and Chief Operating Officer; and Rich Lindahl, Chief Financial Officer. Other members of the senior team are present and available during the Q&A session that will follow our prepared comments.

Before beginning, I will remind everyone that during today's call, either on our prepared comments

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot